Meeting Report

Global Alzheimer Research Summit: Basic and clinical research: Present and future Alzheimer research

Volume 6, Issue 1   January/February/March 2012
Pages 7 - 10
http://dx.doi.org/10.4161/pri.6.1.18854
Keywords: Alzheimer disease, amyloid beta, biomarkers, clinical trials, diagnosis, neurodegeneration, tau, therapeutics, β-secretase, γ-secretase
Authors: Danielle Gonsalves, Katarina Jovanovic, Bianca Da Costa Dias and Stefan F.T. Weiss

View affiliations

Preview



Abstract:

We report here on the proceedings of the Global Alzheimer Summit that took place September 22–23, 2011 in Madrid, Spain. As Alzheimer disease (AD) is the leading cause of neurodegeneration in elderly individuals and as yet has no effective therapeutic option, it continues to stimulate global research interests. At the conference, leaders in the field of AD research provided insights into current developments in various areas of research, namely molecular mechanisms, genetics, novel aspects of AD research and translational research. Emphasis was also placed on the importance of biomarkers in the diagnosis of AD and development of current therapeutic strategies.

Full Text - Ahead of Print Available - Log in!  

Comments

Please Log In to comment on this article.
If you do not have an account Create One Here.
blog comments powered by Disqus
Advertisements